Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali(®)) Versus Etanercept (Enbrel(®)) - Findings from a Nurse Survey in Europe

INTRODUCTION: Enbrel(®) (etanercept: manufactured by Immunex Corporation, Newbury Park, Thousand Oaks, CA 91320, USA) was the first biological disease-modifying anti-rheumatic drug approved for the treatment of rheumatoid arthritis (RA) in Europe. More recently, an etanercept biosimilar (Benepali(®)...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Rheumatol Ther
Main Authors: Thakur, Kunal, Biberger, Anna, Handrich, Alexandra, Rezk, Mourad Farouk
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4999586/
https://ncbi.nlm.nih.gov/pubmed/27747519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-016-0035-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker